1. Home
  2. ATLX vs NKTX Comparison

ATLX vs NKTX Comparison

Compare ATLX & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$4.43

Market Cap

143.1M

Sector

Industrials

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.19

Market Cap

154.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
NKTX
Founded
2011
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.1M
154.8M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
ATLX
NKTX
Price
$4.43
$2.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$11.33
AVG Volume (30 Days)
322.0K
585.8K
Earning Date
05-08-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
47.08
11.88
EPS
N/A
N/A
Revenue
$92,491.00
N/A
Revenue This Year
$64,564.67
N/A
Revenue Next Year
$785.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$1.42
52 Week High
$8.25
$2.81

Technical Indicators

Market Signals
Indicator
ATLX
NKTX
Relative Strength Index (RSI) 45.22 48.72
Support Level $4.32 $1.95
Resistance Level $5.25 $2.32
Average True Range (ATR) 0.31 0.12
MACD -0.01 -0.02
Stochastic Oscillator 36.82 58.58

Price Performance

Historical Comparison
ATLX
NKTX

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: